Investigation of Ischemic Stroke Patients with Mild or Moderate Obstructive Sleep Apnea-hypopnea Syndrome Treated by Nasal Continuous Positive Airway Pressure
TANG Xiao-Mei,YU Feng-Chun,MENG Xiao-Mei,CHEN Xin-Ping,LIU Wei,FENG Hao,ZHU Jian
DOI: https://doi.org/10.3969/j.issn.1673-5765.2013.11.009
2013-01-01
Abstract:Objective To observe the clinical results of ischemic stroke patients with mild and moderate obstructive sleep apnea-hypopnea syndrome treated by nasal continuous positive airway pressure (nCPAP). Methods Sixty-two cases were selected from March 2008 to March 2010 who suffered acute ischemic stroke. After 90 days, thirty patients with mild or moderate obstructive sleep apnea-hypopnea syndrome were enrolled into the study by using polysomnography. Then they were divided into two groups by whether using nCPAP or not:one group (14 cases) accepted treatment with nCPAP, while the other group (16 cases) rejected it. The recurrence rate of stroke, apnea hypopnea index (AHI), blood pressure, body mass index (BMI), Epworth Sleepiness Score (ESS), Hospital Anxiety and Depression Scale (HAD) at the 6th, 12th, 18th, 24th month were measured. Results There were no significant differences between two groups in age, sex, diabetes mellitus,hypertension disease, AHI, systolic pressure, diastolic pressure, BMI, modified Rankin Scale score, ESS, HAD (P value>0.05). There are no recurrent ischemic strokes through two years of observation. The nCPAP group performs better than non-nCPAP group in reducing AHI (nCPAP group AHI:3.9±0.6, 3.8±0.5, 3.9±0.5, 3.8±0.5, non-CPAP group AHI:20.8±4.1, 21.7±4.5, 22.6±4.2, 26.8±6.1, t value 16.2, 15.9, 17.8, 15.0, P value <0.001) and ESS scores (nCPAP group 3.5±1.7, 2.6±1.5, 2.2±1.4, 2.1±1.1, t value 6.1, 8.8, 9.9, 10.0, all P values <0.001), improving the ratio of anxiety in 24th month (P=0.039), while there is subtle difference in the ratio of depression level in the 6th, 12th, 18th, 24th month (nCPAP group:14.3%, 14.3%, 14.3%,14.3%, non-CPAP group:18.8%, 18.8%, 18.8%, 18.8%, P value 1.0, 1.0, 1.0, 1.0) and there is subtle difference in BMI in the 6th, 12th, 18th, 24th month (nCPAP group:22.8±1.4, 23.1±1.4, 22.7±1.4, 22.6±1.4, non-CPAP group:23.3±1.4, 23.7±1.6, 23.5±1.6, 23.0±1.3, P value>0.05). Conclusion It proves that treatment with nCPAP can reduce AHI, decrease ESS scores, and improve the level of anxiety.